Greg Stevenson has worked in the pharmaceutical industry since graduating from the University of St Andrews 30 years ago. In that time, he has focussed on ensuring new medicines get to patients as quickly and safely as possible, initially at Janssen (part of Johnson and Johnson) then at Roche where he was latterly Head of Policy, Partnership and Negotiation for the UK. This work included negotiation and collaboration with Governments, Parliaments and Assemblies, the NHS and patient groups. Many medicines were first in class (able to treat previously untreatable conditions) and needed work to develop new clinical pathways across health systems to ensure patients could access them. Two years ago Greg left his corporate career to set up his own healthcare consultancy business. This has allowed him to work across more sectors, including academia and patient groups, whilst continuing to work with companies from across healthcare. He has two grown up children, one of whom lives with the challenges of Neurofibromatosis Type 1.
